Co-Diagnostics (CODX) Tops Q1 EPS by 10c

Co-Diagnostics (NASDAQ: CODX) reported Q1 EPS of ($0.24), $0.10 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $50 thousand versus the consensus estimate of $400 thousand.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Qualcomm (QCOM) Is Said To Near Deal For Ai Chip Startup Modular - Bloomberg
• Japan's Katayama, Us Treasury's Bessent Hold Online Talks, Source Says - Reuters